RE:Reports Second Quarter of Fiscal 2021 ResultsParticularly impressed with the stable income to be generated from the contract with Focus Medical. Combined with no debt and market penetration of its products, this looks like a company on the move.
It will be interesting to see whether the market acknowledges the one time expense when looking at the bottom line. I imagine SP will build towards the next quarter, regardless.